medigraphic.com

2011, Number 3

Next >>

Rev Cuba Endoc 2011; 22 (3)

Metabolic syndrome: a non diagnosed health problem

Bustillo SE, Pérez FY, Brito GA, González IA, Castañeda MD, Santos GM, Bustillo ME

Language: Spanish
References: 44
Page: 167-181
PDF size: 98.83 Kb.


ABSTRACT

Introduction: a cross-sectional on prevalence was conducted in the north area of the Sancti Spiritus city from January, 2006 to December, 2009.
Objective: to determine the prevalence of metabolic syndrome according the criteria of the Latin-American of Diabetes.
Methods: the study universe included persons aged 16 or more from 20 randomized consulting rooms, which accounted for the 40 % of north area total. The averaged sample was of 913 persons where 1 019 were polled and assessed. The 93,62 % were residents of urban area. Home selection was made through a randomized number table.
Results: global prevalence of metabolic syndrome increased significantly with age of the person (≥ 50 years old) with a body mass index (≥ 25 kg/m²) with the urban origin persons and with the glucose metabolism deterioration.
Conclusions: prevalence of metabolic in study population is high.


REFERENCES

  1. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.

  2. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation: European Group for the Study of Insulin Resistance (EGIR). Diabet Med. 1999;16:442-3.

  3. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109:433-8.

  4. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocr Pract. 2003;9:237-52.

  5. Alberti KG, Zimmet PZ, Shaw JE. The Metabolic Syndrome-A New Worldwide Definition from the International Diabetes Federation Consensus. Lancet. 2005;366:1059-62.

  6. Grupo de Trabajo del Síndrome Metabólico. ALAD. Consenso Latinoamericano de la Asociación Latinoamericana de Diabetes (ALAD). Epidemiología, Diagnóstico, Control, Prevención y Tratamiento del Síndrome Metabólico en Adultos [homepage en internet] 2007 [citado 1º de septiembre de 2010]. Disponible en: http://www.hospitalameijeiras.sld.cu/hha/images/presentaciones/medicinainterna/SIMPOSIO DE DIABETES Y SINDROME METABOLICO/Consenso de Sindrome MetabolicoAdultos/ConsensoSindromeMetabolicoAdultos.pdf

  7. Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008;28:629-36.

  8. Love A, Oldford D. Metabolic syndrome. Can J Cardiovasc Nurs. 2005;5:6-8.

  9. Mancia G. The association of hypertension and diabetes: prevalence, cardiovascular risk and protection by blood pressure reduction. Acta Diabetol. 2005;42 Suppl 1:S17- 25.

  10. Rosas J, Torres M, Calzada R, Sinay I, Costa J. Guía ALAD. Diagnóstico, control, prevención y tratamiento del síndrome metabólico en pediatria. Rev ALAD [serie en internet] 2009 [citado 1º de septiembre de 2010]. Disponible en: http://revistaalad.com.ar/website/articulo.asp?id=87

  11. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26:3160-7.

  12. Morejón Giraldoni AF, Benet Rodríguez M, Diez y Martínez de la Cotera E, García Torres D, Salas Rodríguez V, Ordúñez García PO. Síndrome metabólico en un área de salud de Cienfuegos. Segunda medición de CARMEN. Finlay. 2011;1:6-14.

  13. Escobedo J, Schargrodsky H, Champagne B, Silva H, Boissonnet CP, Vinueza R, et al. Prevalence of the Metabolic Syndrome in Latin America and its association with sub-clinical carotid atherosclerosis: the CARMELA cross sectional study. Cardiovascular Diabetology. 2009;8:52.

  14. Ford E. Prevalence of the Metabolic Syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28:2 745-9.

  15. Lorenzo C, Serrano-Ríos M, Martínez-Larrad MT, González-Sanchez JL, Seclén S, Villena A. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjetcs. Diabetes Care. 2006;29:685-93.

  16. Bener A, Zirie M, Musallam M, Khader YS, Al-Hamaq AO. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study. Metab Syndr Relat Disord. Jun 2009;7:221-9.

  17. Valenzuela AA, Maíz A, Margozzini P, Ferreccio C, Rigotti A, Olea R, et al. Prevalence of metabolic syndrome among Chilean adults. Rev Med Chil. 2010;138:707-14.

  18. Rojas R, Aguilar-Salinas CA, Jiménez-Corona A, Shamah-Levy T, Rauda J, Ávila- Burgos L, et al. Metabolic syndrome in Mexican adults. Results from the National Health and Nutrition Survey 2006. Salud Pública Mex. 2010;52 supl 1:S11-S8.

  19. Hollman G, Kristenson M. The prevalence of the metabolic syndrome and its risk factors in a middle-aged Swedish population-mainly a function of overweight? Eur J Cardiovasc Nurs. 2007;7:21-6.

  20. Villegas R, Creagh D, Hinchion R, O'Halloran D, Perry IJ. Prevalence and lifestyle determinants of the metabolic syndrome. Ir Med J. 2004;97:300-3.

  21. Liu J, Hanley AJ, Young TK, Harris SB, Zinman B. Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada. Int J Obes (Lond). 2006;30:669-76.

  22. Leite ML, Nicolosi A, Firmo JO, Lima-Costa MF. Features of metabolic syndrome in non-diabetic Italians and Brazilians: a discriminant analysis. Int J Clin Pract. 2007;61:32-8.

  23. Zabetian A, Hadaegh F, Azizi F. Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract. 2007;77:251-7.

  24. Hwang LC, Bai CH, Chen CJ. Prevalence of obesity and metabolic syndrome in Taiwan. J Formos Med Assoc. 2006;105:626-35.

  25. Khader Y, Bateiha A, El-Khateeb M, Al-ShaikhA, Ajlouni K. High prevalence of the metabolic syndrome among Northern Jordanians. J Diabetes Complications. 2007;21:214-9.

  26. Cameron AJ, Magliano DJ, Zimmet PZ, Welborn T, Shaw JE. The metabolic syndrome in Australia: prevalence using four definitions. Diabetes Res Clin Pract. 2007;77:471-8.

  27. Cornier MA, Dabelea D, Hernandez TL, Lindstrom RC, Steig AJ, Stob NR, et al. The Metabolic Syndrome. Endocr Rev. 2008;29:777- 822.

  28. Hildrum B, Mykletun A, Torstein H, Midthjell K, Dahl AA. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study. BMC Public Health. 2007;7:220.

  29. Csaszar A, Kekes E, Abel T, Papp R, Kiss I, Balogh S. Prevalence of metabolic syndrome estimated by International Diabetes Federation criteria in a Hungarian population. Blood Press. 2006;15:101-6.

  30. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33:351-75.

  31. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988- 1994. Arch Intern Med. 2003;163:427-36.

  32. Yi Z, Jing J, Xiu-ying L, Hongxia X, Jianjun Y, Yuhong Z. Prevalence of the Metabolic Syndrome among rural original adults in NingXia, China. BMC Public Health. 2010;10:140.

  33. Elia M. Obesity in the elderly. Obes Res. 2001;9(Suppl 4):244S-8S.

  34. Jones ED, Ivanov LL, Wallace DC, Von Cannon L. Examining the metabolic syndrome in Russia. Int J Nurs Pract. 2006;12:260-6.

  35. Weng X, Liu Y, Ma J, Wang W, Yang G, Caballero B. An urban-rural comparison of the prevalence of the metabolic syndrome in eastern China. Public Health Nutr. 2007;10:131-6.

  36. Mahadik SR, Deo SS, Mehtalia SD. Increased prevalence of metabolic syndrome in non-obese Asian Indian an urban-rural comparison. Metab Syndr Relat Disord. 2007;5:142-52.

  37. Kozan O, Oguz A, Abaci A, Erol C, Ongen Z, Temizhan A, et al. Prevalence of the metabolic syndrome among Turkish adults. Eur J Clin Nutr. 2007; 61:548-53.

  38. Lim S, Jang HC, Lee HK, Kimm KC, Park C, Cho NH. A rural-urban comparison of the characteristics of the metabolic syndrome by gender in Korea: the Korean Health and Genome Study (KHGS). J Endocrinol Invest. 2006;29:313-9.

  39. Carnethon MR, Loria CM, Hill JO, Sidney S, Savage PJ, Liu K. Risk factors for the Metabolic Syndrome. The Coronary Artery Risk Develoment in Young Adults (CARDIA) study, 1985-2001. Diabetes Care. 2004;2707-15.

  40. Cheung B, Wat N, Man Y B, Tam S, Thomas GN, Leung GM, et al. Development of diabetes in chinese with metabolic syndrome. A 6-year prospective study. Diabetes Care. 2007;30:1430-36.

  41. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D' Agostino RB, Wilson PWF. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care. 2007;30:3 219-25.

  42. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S, Laakso M, et al. Prevalence of the metabolic syndrome and its components. Findings from a Finnish general population simple and the Diabetes Prevention Study cohort. Diabetes Care. 2004;27:2 135-40.

  43. Isomas B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbility and mortality associated with the MetS. Diabetes Care. 2001;24:683-9.

  44. Muñoz MJ, Peña M, Hernández FF, Pérez JF, Soler I, Just Matos CC. Síndrome metabólico en pacientes diabéticos tipo 2 pertenecientes al área de salud Guanabo. Rev Cubana Med Gen Integr [serie en internet]. 2010 [citado 1º de septiembre de 2010];26(2). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252010000200008&lng=es&nrm=iso




2020     |     www.medigraphic.com